ABSTRACTMycobacterial shuttle vectors contain dual origins of replication for growth in bothEscherichia coliand mycobacteria. One such vector, pSUM36, was re-engineered for high-level protein expression in diverse bacterial species. The modified vector (pSUM-kan-MCS2) enabled green fluorescent protein expression inE. coli,Mycobacterium smegmatis, andM. aviumat levels up to 50-fold higher than that detected with the parental vector, which was originally developed with alacZα promoter. This high-level fluorescent protein expression allowed easy visualization ofM. smegmatisandM. aviumin infected macrophages. TheM. tuberculosisgeneesat-6was cloned in place of the green fluorescence protein gene (gfp) to determine the impact of ESAT-6 on the innate inflammatory response. The modified vector (pSUM-kan-MCS2) yielded high levels of ESAT-6 expression inM. smegmatis. The ability of ESAT-6 to suppress innate inflammatory pathways was assayed with a novel macrophage reporter cell line, designed with an interleukin-6 (IL-6) promoter-driven GFP cassette. This stable cell line fluoresces in response to diverse mycobacterial strains and stimuli, such as lipopolysaccharide.M. smegmatisclones expressing high levels of ESAT-6 failed to attenuate IL-6-driven GFP expression. Pure ESAT-6, produced inE. coli, was insufficient to suppress a strong inflammatory response elicited byM. smegmatisor lipopolysaccharide, with ESAT-6 itself directly activating the IL-6 pathway. In summary, a pSUM-protein expression vector and a mammalian IL-6 reporter cell line provide new tools for understanding the pathogenic mechanisms deployed by various mycobacterial species.